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 Channel Mediates the Zinc Switch-Off
Signal for Glucagon Response During Glucose
Deprivation
Michela Slucca, Jamie S. Harmon, Elizabeth A. Oseid, Joseph Bryan, and R. Paul Robertson
OBJECTIVE—The intraislet insulin hypothesis proposes that
glucagon secretion during hypoglycemia is triggered by a de-
crease in intraislet insulin secretion. A more recent hypothesis
based on in vivo data from hypoglycemic rats is that it is the
decrease in zinc cosecreted with insulin from -cells, rather than
the decrease in insulin itself, that signals glucagon secretion from
-cells during hypoglycemia. These studies were designed to
determine whether closure of the -cell ATP-sensitive K
 chan-
nel (KATP channel) is the mechanism through which the zinc
switch-off signal triggers glucagon secretion during glucose
deprivation.
RESEARCH DESIGN AND METHODS—All studies were per-
formed using perifused isolated islets.
RESULTS—In control experiments, the expected glucagon re-
sponse to an endogenous insulin switch-off signal during glucose
deprivation was observed in wild-type mouse islets. In experi-
ments with streptozotocin-treated wild-type islets, a glucagon
response to an exogenous zinc switch-off signal was observed
during glucose deprivation. However, this glucagon response to
the zinc switch-off signal during glucose deprivation was not seen
in the presence of nifedipine, diazoxide, or tolbutamide or if KATP
channel knockout mouse islets were used. All islets had intact
glucagon responses to epinephrine.
CONCLUSIONS—These data demonstrate that closure of KATP
channels and consequent opening of calcium channels is the
mechanism through which the zinc switch-off signal triggers
glucagon secretion during glucose deprivation. Diabetes 59:
128–134, 2010
T
reatment with exogenous insulin places patients
with type 1 or advanced type 2 diabetes at high
risk for hypoglycemia. Under normal circum-
stances, the physiologic response to hypoglyce-
mia involves multiple intrinsic defense mechanisms. These
include inputs from the central nervous system and re-
lease of glucagon, epinephrine, growth hormone, and
cortisol. Chief among these is the increase in glucagon
secretion. In diabetic patients, the counterregulatory glu-
cagon response is severely compromised. A leading hy-
pothesis to explain this abnormality is referred to as the
“intraislet insulin hypothesis” (1–3). Banarer et al. (1)
based this hypothesis on an earlier observation by Samols
et al. (4), who identiﬁed a unidirectional blood ﬂow within
the pancreatic islet whereby arterial blood from the sys-
temic circulation ﬁrst reaches -cells in the islet core, then
-cells in the islet periphery, and ﬁnally leaves the islet to
enter the hepatic portal venous circulation. In this manner,
products released from upstream -cells inﬂuence the
function of downstream -cells. Many in vitro and in vivo
studies support this hypothesis that proposes that insulin
tonically suppresses glucagon secretion in the presence of
high or normal glucose levels and that a sudden cessation
of insulin secretion caused by hypoglycemia triggers glu-
cagon secretion.
However, it has been pointed out that, together with
insulin, -cells release other mediators that suppress glu-
cagon secretion and thus could provide switch-off signals
to the -cell to enhance glucagon secretion. Among them,
attention has been focused on -aminobutyric acid (5–7)
and zinc (8,9). We concentrated on the role zinc might play
in the intraislet insulin hypothesis. In this scenario, zinc
coreleased with insulin from upstream -cells in the
presence of high glucose inhibits glucagon secretion;
when blood glucose levels fall, zinc secretion from -cells
decreases and glucagon secretion is triggered. The
potential role of zinc as a switch-off signal has been
demonstrated by us in an in vivo study in which
switching off either an insulin or a zinc infusion into the
pancreatic artery of streptozotocin (STZ)-treated rats
during hypoglycemia stimulated glucagon secretion. In
contrast, switching-off zinc-free insulin failed to elicit
glucagon secretion (9).
The current studies were designed to identify the mech-
anism of action whereby zinc regulates -cell function
during hypoglycemia. We hypothesized that KATP channels
in -cells play a central role. We experimented by phar-
macologically manipulating the KATP channel activity of
wild-type mouse islets as well as with a mouse model
derived from the wild-type control but in which the SUR1
subunit of the KATP channel (SUR1KO) had been knocked
out (10). We raised two independent questions. First, can
a role for cessation of secretion of insulin (and by impli-
cation zinc coreleased with insulin) as a switch-off signal
during hypoglycemia be demonstrated in vitro using peri-
fused mouse islets? This initial question was essential to
answer because of a report by Ravier and Rutter (11) that
zinc does not regulate glucagon secretion in mice. Second,
does the mechanism of action for the switch-off signal
from zinc speciﬁcally rely on functional KATP channels? An
endogenous insulin switch-off signal was created by
stimulating endogenous insulin secretion with glucose
perifusion then abruptly decreasing insulin secretion by
discontinuing the glucose perifusion. An exogenous zinc
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of insulin secretion was created in STZ-treated wild-type
mouse islets by perifusing and then discontinuing the
perifusion of zinc chloride and glucose. This zinc switch-
off signal during glucose deprivation was further investi-
gated in the presence of diazoxide (to maintain KATP
channels open), nifedipine (to close calcium channels), or
tolbutamide (to close potassium channels). Finally, the
zinc switch-off signal was studied using mouse islets with
knocked out KATP channels.
RESEARCH DESIGN AND METHODS
Male and female wild-type C57BL6/J mice (8–15 weeks old) were purchased from
Jackson Labs (JAX no. 000664). SUR1 knockout mice (SUR1KO) were bred at
PNDRI (10). Animals were maintained with a 12-h light-dark cycle and constant
temperature and were given free access to food and water. All experiments were
approved by the PNDRI Institutional Animal Care and Use Committee.
Islet isolation. On the day of pancreas removal, animals were anesthetized
with ketamine-xylazine and then killed by removing blood from the heart.
Pancreata were cannulated for infusion of collagenase and then removed from
the animal for processing. Mice pancreata were processed as described by
Tanaka (12), using 0.75 mg/ml collagenase in wild-type mice and 1.5 mg/ml
collagenase in SUR1KO mice. A higher concentration was used for SUR1KO
mouse islets since they tended to adhere to ducts when the lower concentra-
tion was used. Once processed, islets were hand picked and cultured
overnight in RPMI 1640 media with 11.1 mmol/l glucose, 10% FBS, and
antibiotic/antimycotic (100 units/ml penicillin G and 0.1 mg/ml streptomycin
sulfate and 0.25 g/ml amphoteracin B). The pool of islets for each experiment
was derived from at least eight animals. In some experiments STZ was used to
render pancreatic islets devoid of -cells. In these experiments, isolated islets
were cultured for2hi nRPMI media with 11.1 mmol/l glucose, 10% FBS, and
antibiotic/antimycotic then for 30 min in RPMI media with STZ (5 mmol/l),
11.1 mmol/l glucose, 0.8% FBS, and antibiotic/antimycotic. Then, STZ was
washed out of the islets and they were cultured overnight in RPMI media with
11.1 mmol/l glucose, 10% FBS, and antibiotic/antimycotic.
Perifusion. The day after isolation, islets were split into groups of 200 islets.
Each group was placed into one of the individual perifusion chambers for
simultaneous study. The islets were placed in the chambers on top of mesh
ﬁlters (60 m) small enough to prevent islets from escaping into the efﬂuent.
Each experiment was preceded by a 60-min stabilization period using a
perifusion of Kreb’s Ringer buffer (KRB) containing 0.1% BSA, 0.238% HEPES,
0.1 mmol/l isobutylmethylxanthine (IBMx), and 2.8 mmol/l glucose. Thereaf-
ter, experimental KRB buffers contained 0.1% BSA, 0.238% HEPES, 0.1 mmol/l
IBMx, an amino acid mixture (3), and either 16.7 or 0 mmol/l glucose. When
STZ-treated islets were used, 30 mol/l zinc chloride was also included in the
buffer. Samples for measurement of insulin and glucagon were collected at
10, 5, 2, 1, and 0 min before and 2, 5, 10, 15, 20, 25, and 30 min after
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FIG. 1. A. Endogenous insulin switch-off signal to -cells in WT islets. Isolated islets were exposed to 16.7 mmol/l glucose (16.7G) for 30 min
(from 30 to 0 min). At min 0 the perifusion was either changed to 0 glucose or not changed for the ensuing 30 min. The closed circles at times
10 to 0 min represent the average of experimental and control values when islets were exposed to 16.7 mmol/l glucose. Insulin secretion
declined when glucose infusion was changed to 0 mmol/l at time 0 min, generating an endogenous insulin switch-off signal from -cells to
neighboring -cells (closed boxes). Insulin levels did not decrease signiﬁcantly when the glucose perifusion was not changed (closed diamonds).
Results are expressed as mean  SE of eight replicate perifusions in experimental studies (closed boxes) and seven replicate perifusions in
control studies (closed diamonds). See text for statistical information. A and B: Glucagon responses to an endogenous insulin switch-off signal
during perifusion of wild-type mouse islets. Glucagon levels increased signiﬁcantly only when endogenous insulin secretion (A) was switched-off
in response to glucose deprivation at time 0 min (f, n  8). No glucagon response was observed if the endogenous insulin switch-off signal was
absent (, n  7). F at times 10 to 0 min represent the average of experimental and control values. See text for statistical information.
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FIG. 2. Glucagon response in the presence and absence of an exoge-
nous zinc switch-off signal during perifusion of STZ-induced diabetic
wild-type mouse islets. Islets were pretreated with STZ to kill -cells,
thereby preventing endogenous insulin and zinc secretion. After an
initial 30-min perifusion with 16.7 mmol/l glucose and zinc (Zn), at time
0 min the perifusate was changed. Glucagon levels increased signiﬁ-
cantly only when a perifusate containing no glucose and no zinc, which
generated an exogenous zinc switch-off signal to -cells during glucose
deprivation, was begun at 0 min (f, n  5). Glucagon secretion did not
increase if at time 0 min only glucose, but not zinc, was switched off (E,
n  4) or if only zinc but not glucose was switched off (F, n  4). If at
time 0 min nifedipine (NIF) was added to the perifusate, glucagon
secretion not only failed to rise but was suppressed despite the
presence of the zinc switch-off signal during glucose deprivation (,
n  3). Œ at times 10 to 0 min represent the average of experimental
values and control values.
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diabetes.diabetesjournals.org DIABETES, VOL. 59, JANUARY 2010 129endogenous insulin (Fig. 1) and exogenous zinc (Figs. 2, 3 and 4) switch-off
signals were provided at time 0.
The rationale for choosing the concentration of 30 mol/l for zinc chloride
is provided in a previous publication (9). During exposure to physiologic or
elevated glucose levels, the zinc-insulin complex is released from the -cell
into the periportal circulation that travels to -cells. This design assumes that
zinc dissociates from insulin when exposed to the higher pH of blood (13) and
acts to open -cell KATP channels, which causes tonic suppression of glucagon
secretion. It also assumes that zinc is normally bound to protein in blood, as
it dissociates from insulin in the periportal circulation and circulates to the
-cell, and that zinc concentration during glucose stimulation of insulin
release is fourfold greater (9) than the 10 mmol/l concentration found in
systemically circulating blood. This fourfold higher concentration of zinc is
assumed to drop to the same levels found in systemically circulating blood
during glucose deprivation and cessation of insulin secretion.
Drugs: nifedipine, diazoxide, tolbutamide, epinephrine. Nifedipine: a 1
mol/l perifusion solution was prepared from a 1 mmol/l stock solution in
100% ethanol. Diazoxide: a 50 mol/l perifusion solution was prepared from a
50 mmol/l stock solution in 0.1 mol/l NaOH. Tolbutamide: a 50 mol/l
perifusion solution was prepared from a 50 mmol/l stock solution in 100%
ethanol. Epinephrine: a 1 mol/l perifusion solution was prepared from a 1
mmol/l stock solution in 1 mol/l HCl. Epinephrine was infused in the absence
of glucose and the amino acid mixture for 5–7 min at the end of each
experiment as alternative stimulus for glucagon secretion to ensure that
-cells were still functional after STZ treatment. Nifedipine, diazoxide, tolbu-
tamide, and epinephrine were purchased from Sigma.
Assays. Perifusion samples were collected into tubes containing 500 units of
aprotinin to prevent degradation of glucagon. Insulin was measured by
radioimmunoassay according to the method of Morgan and Lazarow (14).
Glucagon was measured using a glucagon radioimmunoassay kit (Millipore,
St. Charles, MO).
Statistical analysis. Results for each perifusion experiment were calculated
as means  SE. Measurements of at least three lanes were considered as n 
1. Comparisons were made by paired Student’s t test, unpaired Student’s t test
with or without Welch correction, Wilcoxon matched-pairs signed-ranks test,
and ANOVA, where appropriate. P values 	0.05 were considered signiﬁcant.
RESULTS
Endogenous insulin switch-off signal in wild-type
mouse islets. Wild-type mouse islets were perifused with
16.7 mmol/l glucose for 30 min to stimulate endogenous
insulin secretion. At time 0, the perifusate was switched to
a 0 mmol/l glucose buffer for 30 min so that endogenous
insulin secretion would decrease. In control experiments,
at time 0, 16.7 mmol/l glucose was continued rather than
discontinued. Insulin levels in the efﬂuent decreased when
the 16.7 mmol/l glucose perifusion was discontinued (0
min  108  7 U/ml, 30 min  5  1 U/ml, n  8; P 	
0.001) (Fig. 1A). When the 16.7 mmol/l glucose perifusion
was not discontinued, insulin levels did not change signif-
icantly (0 min  107  10 U/ml, 30 min  90  8 U/ml,
n  7; P  NS) (Fig. 1A). Glucagon levels increased
signiﬁcantly only when 16.7 mmol/l glucose buffer was
discontinued (0 min  61  8 pg/ml vs. 30 min  133  26
pg/ml, n  8; P 	 0.01) (Fig. 1B) and not when the glucose
perifusate was continued for the duration of the experi-
ment (0 min  54  9 pg/ml vs. 30 min  71  14 pg/ml,
n  7; P  NS) (Fig. 1B).
Exogenous zinc switch-off signal in STZ-induced dia-
betic wild-type mouse islets. STZ-induced diabetic
wild-type islets were perifused with 16.7 mmol/l glucose
and zinc (30 mol/l) for 30 min. Then, at time 0, both
glucose and zinc perifusions were discontinued. In
controls, either glucose or zinc alone was discontinued.
In other experiments, at time 0 nifedipine was added to
the perifusate when zinc was switched off during glu-
cose deprivation (Fig. 2). Glucagon levels increased
only when zinc perifusion was switched off during
glucose deprivation (0 min  28  6 pg/ml vs. 30 min 
50  4 pg/ml, n  5; P 	 0.02) (Fig. 2). If the zinc
perifusion was continued during glucose deprivation,
glucagon levels did not rise signiﬁcantly (0 min  15 
2 pg/ml vs. 30 min  23  3 pg/ml, n  4; P  NS) (Fig.
2). Similarly, if perifusion containing glucose was con-
tinued after the zinc perifusion was switched off, the
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FIG. 3. Glucagon responses from STZ-induced diabetic wild-type mouse
islets to an exogenous zinc switch-off signal during glucose deprivation
in the presence of diazoxide. After an initial 30-min perifusion with
16.7 mmol/l glucose, diazoxide (DZX), and zinc, both glucose and zinc
were discontinued at time 0 min and only diazoxide was continued for
the last 30 min. Diazoxide prevented any signiﬁcant increase in
glucagon secretion despite the presence of a zinc switch-off signal
during glucose deprivation (, n  3). For the purpose of comparison,
f are the same data reported in Fig. 2 and represent the glucagon
response to a zinc switch-off signal during glucose deprivation in the
absence of diazoxide infusion. See text for statistical information.
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FIG. 4. Glucagon responses from STZ-induced diabetic wild-type mouse
islets to an exogenous zinc switch-off signal during glucose deprivation in
the presence of tolbutamide (50 mol/l). After an initial 30-min perifusion
with 16.7 mmol/l glucose, tolbutamide (TLB), and zinc, both glucose and
zinc were discontinued at time 0 min and only tolbutamide was continued
for the last 30 min. Tolbutamide prevented any signiﬁcant increase in
glucagon secretion despite the presence of a zinc switch-off signal during
glucose deprivation (, n  3). For the purpose of comparison, f are the
same data reported in Fig. 2 and represent the glucagon response to a zinc
switch-off signal during glucose deprivation in the absence of tolbutamide
infusion. The glucagon response is expressed as percentage of baseline
because of the higher glucagon baseline in the islets perifused with
tolbutamide due to tolbutamide-mediated closure of the KATP channels.
See text for statistical information.
ZINC, KATP CHANNEL, GLUCAGON, GLUCOSE DEPRIVATION
130 DIABETES, VOL. 59, JANUARY 2010 diabetes.diabetesjournals.orgglucagon levels did not rise (0 min  18  4 pg/ml vs. 30
min  25  7 pg/ml, n  4; P  NS) (Fig. 2). In the
presence of nifedipine, glucagon levels after the zinc
switch-off signal during glucose deprivation did not
increase but signiﬁcantly decreased (0 min  36  5
pg/ml vs. 30 min  11  1 pg/ml, n  3; P 	 0.05) (Fig.
2). Insulin levels were undetectable throughout.
Exogenous zinc switch-off signal during diazoxide
infusion in STZ-induced diabetic wild-type mouse
islets. STZ-induced diabetic wild-type mouse islets were
perifused with 16.7 mmol/l glucose and diazoxide (50
mol/l) for 30 min (60 to 30 min), followed by a
perifusate containing 16.7 mmol/l glucose, diazoxide, and
zinc (30 mol/l) for another 30 min (30 to 0 min). At 0
min, both glucose and zinc were discontinued and diazox-
ide infusion only was continued for 30 more minutes (Fig.
3). Glucagon secretion remained suppressed despite the
absence of glucose and zinc in the perifusate (0 min 
10  0 pg/ml vs. 30 min  14  2 pg/ml, n  3; P  NS)
(Fig. 3). Insulin levels were undetectable throughout.
Exogenous zinc switch-off signal during tolbutamide
infusion in STZ-induced diabetic wild-type mouse
islets. STZ-induced diabetic wild-type mouse islets were
perifused with 16.7 mmol/l glucose and tolbutamide (50
mol/l) for 30 min (60 to 30 min), followed by a
perifusate containing 16.7 mmol/l glucose, tolbutamide,
and zinc (30 mol/l) for another 30 min (30 to 0 min). At
0 min, both glucose and zinc were discontinued and
tolbutamide infusion only was continued for 30 more
minutes (Fig. 4). Glucagon secretion reached a higher
baseline than in the previous STZ-induced diabetic islet
experiments and it did not rise signiﬁcantly when zinc was
switched off during glucose deprivation (0 min  53  5
pg/ml vs. 30 min  67  3 pg/ml, n  3; P  NS) (Fig. 4).
Insulin levels were undetectable throughout.
Exogenous zinc switch-off signal in STZ-induced dia-
betic SUR1KO mouse islets. An exogenous zinc switch-
off signal during glucose deprivation was provided to
STZ-induced diabetic SUR1KO mouse islets by infusing
16.7 mmol/l glucose and zinc (30 mol/l) for 30 min and
then switching to a perifusate without glucose and zinc at
time 0 (Fig. 5). No signiﬁcant glucagon increase was
observed despite the provision of a zinc switch-off signal
during glucose deprivation (0 min  55  17 pg/ml vs. 30
min  61  20 pg/ml; n  4, P  NS). Insulin levels were
undetectable throughout.
Summary of glucagon responses with and without
interfering with the KATP channel activity. Glucagon
levels before and after infusion of drugs that interfere with
KATP channel activity in wild-type or SUR1KO islets are
shown in Fig. 6A. Compared with wild-type values, depo-
larizing conditions (tolbutamide, knockout) were associ-
ated with higher glucagon levels (P 	 0.05), and the
polarized condition (diazoxide) was associated with lower
glucagon levels (P 	 0.05) at baseline (time 0). Glucagon
responses to changes in the perifusate in STZ-induced
diabetic mouse islets are compared as area under the
curve in Fig. 6B. Glucagon response was statistically
signiﬁcant (P 	 0.01–0.001) only when a zinc switch-off
signal during glucose deprivation was provided to wild-
type islets pretreated with STZ. No statistically signiﬁcant
glucagon responses were observed if zinc or glucose perifu-
sions alone were discontinued or a zinc switch-off signal
during glucose deprivation was provided in the presence of
nifedipine, diazoxide, tolbutamide, or to SUR1KO islets.
Responses to epinephrine. -Cell function was tested at
the end of most experiments using a 5- to 7-min infusion of
epinephrine as alternative stimulus. Glucagon responses
were intact in all the conditions involving wild-type and
knockout islets (Fig. 7).
DISCUSSION
These experiments were designed to identify the mecha-
nism through which zinc provides a switch-off signal for
glucagon release during glucose deprivation. We previ-
ously reported that switching off zinc and insulin, but not
zinc-free insulin, triggered glucagon secretion during hy-
poglycemia in vivo in rats (9). The results from the ﬁrst
part of the current study are consistent with a role for
cessation of zinc corelease with insulin as a switch-off
signal to trigger glucagon secretion during glucose depri-
vation. Since our experiments used mouse islets, our data
argue against the contention of Ravier and Rutter (11) that
zinc does not regulate -cells in mice and support the
more recent ﬁndings by Gyulkhandanyan et al. (15).
The second part of our study was designed to identify
the mechanism of action for zinc regulation of the -cell.
To achieve this goal, we used two approaches. The ﬁrst
approach was to pharmacologically manipulate the KATP
channel with drugs prior to providing STZ-induced dia-
betic wild-type mouse islets with a zinc switch-off signal
during glucose deprivation. The ﬁrst drug was diazoxide
that keeps the KATP channels open. The rationale was that
if the zinc switch-off signal is mediated by a change in the
KATP channel activity, then using diazoxide to prevent any
further change in the KATP channel activity should blind
the KATP channel to the zinc switch-off signal. Zinc removal
from the perifusate during glucose deprivation induced no
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FIG. 5. Glucagon responses in the presence of an exogenous zinc
switch-off signal during perifusion of STZ-induced diabetic SUR1KO
mouse islets. STZ-induced diabetic SUR1KO mouse islets were peri-
fused with 16.7 mmol/l glucose and zinc for 30 min. Then, at time 0 min,
both glucose and zinc were discontinued. Glucagon secretion from
SUR1KO mouse islets failed to increase despite the presence of a zinc
switch-off signal during glucose deprivation (, n  4). For the
purpose of comparison, f are the same data reported in Fig. 2 and
represent the glucagon rise in response to a zinc switch-off signal
during glucose deprivation in STZ-induced diabetic wild-type mouse
islets. The glucagon response is expressed as a percentage of baseline
because of the higher glucagon baseline in SUR1KO mouse due to the
absence of KATP channels. See text for statistical information.
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lets. This suggests that by maintaining the KATP channels
open, the drug masked and overrode the signal given by
zinc removal. In other mechanistic studies, we interfered
with the KATP channel activity using tolbutamide. This
drug, which keeps KATP channels closed, led to the same
result. Because of the tolbutamide-mediated prestimula-
tion of KATP channel activity, the already closed KATP
channels failed to respond to the signal provided by the
switch-off of zinc during glucose deprivation. We also
examined whether the post–KATP channel signal transduc-
tion pathway involved calcium channels. Nifedipine was
used to prevent the calcium channels from opening. Since
zinc does not act on calcium channels, no preinfusion (as
with the diazoxide and tolbutamide experiments) with
nifedipine was deemed necessary. In the presence of
nifedipine, glucagon secretion failed to respond to the zinc
switch-off signal during glucose deprivation. These results
suggest that the pathway through which the zinc switch-off
signal triggers glucagon secretion during glucose depriva-
tion involves both KATP and calcium channels (Fig. 8). Our
ﬁndings also demonstrate that the -cell is responsive to
the zinc switch-off signal only in the circumstance of
glucose deprivation, consistent with the fact that glucose
is widely recognized as a suppressant of glucagon secre-
tion (16,17).
The second approach used a model derived from the
mouse line C57BL6/J, whose SUR1 subunit of the KATP
channel is knocked out (10). Islet KATP channels consist of
two subunits: the K
 inward rectiﬁer, Kir6.2, and the
high-afﬁnity sulfonylurea receptor, SUR1, combined in 4:4
stoichiometry to form the hetero-octomeric channel. The
Kir6.2 subunit forms the conducting pore for K
 ions,
while the SUR1 subunit acts as a regulatory subunit
conferring sensitivity to openers and blockers (18–20). A
tight interaction between the two subunits is required
for appropriate channel function. In our experiments,
although SUR1KO mouse islets were exposed to an
exogenous zinc switch-off signal during glucose depri-
vation, glucagon secretion failed to respond. Impor-
tantly, SUR1KO mouse islets, as well as wild-type islets,
responded to the alternative stimulus epinephrine, a
known stimulator of glucagon secretion (21). Glucagon
responses to this stimulus indicate that -cell glucagon
synthesis and exocytotic mechanisms are intact.
Our data reinforce the hypothesis that an intercellular
dialogue is critical within the pancreatic islet for optimal
glycemic control (4) and that zinc participates to this
dialogue and therefore to the regulation of glucagon
secretion by acting through the SUR1 subunit of the KATP
channels as reported by other groups (8,22–25). In this
scenario, during exposure to physiologic or elevated glu-
cose levels, the zinc-insulin complex is released from the
-cell into the periportal circulation that travels to -cells.
Zinc dissociates from insulin when exposed to the higher
pH of blood (13) and acts to open -cell KATP channels,
which causes tonic suppression of glucagon secretion.
However, during states of glucose deprivation, such as
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signal during glucose deprivation and at time 30 min (means  SE). Compared with the untreated wild-type islets, baseline glucagon levels at
time 0 min were higher in the depolarized state (TLB, KO) and lower in the polarized state (DZX), all P < 0.05. At time 30 min, no differences
were noted among the groups. A signiﬁcant difference was noted when comparing time 0 to time 30 min in the untreated wild-type islet group
(P < 0.02). B: Glucagon responses expressed as area under the curve (AUC) after zinc switch-off signal. A statistically signiﬁcant (P < 0.001)
glucagon response occurred only when a zinc switch-off signal was provided during glucose deprivation in wild-type islets pretreated with STZ.
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FIG. 7. Glucagon responses to epinephrine. Glucagon responses to
epinephrine were intact in both wild-type and SUR1KO islets. , ,
and hatched diamonds represent data obtained, respectively, from
wild-type islets, STZ-induced diabetic wild-type islets, and STZ-
induced diabetic SUR1KO islets. The glucagon response correlated
signiﬁcantly with the prestimulated glucagon level.
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lin. This results in cessation of zinc effects on -cell KATP
channels and closure of the channels, which in turn causes
depolarization, voltage-dependent calcium channel open-
ing, calcium entry, and glucagon exocytosis (Fig. 8).
In support of this mechanism is the observation that the
glucagon values reached during the -cell response to the
zinc switch-off signal during glucose deprivation in wild-
type mouse islets were very similar to the values of the
glucagon baselines in wild-type mouse islets perifused
with tolbutamide and in knockout mouse islets (Fig. 6A).
Thus, switching off zinc, closing the KATP channels by
means of tolbutamide, and absent KATP channels (as
occurs in the KO mice) depolarize the -cell, causing Ca
2
channels to open and increase glucagon secretion. On the
other hand, adding diazoxide to the perifusate keeps KATP
channels open, supporting K
 efﬂux, which keeps the cell
polarized and thus prevents Ca
2 channels from opening,
resulting in less glucagon secretion. Different from previ-
ous studies by others, our observations were obtained
from intact and STZ-induced diabetic mouse islets, using a
dynamic system that speciﬁcally studied glucagon secre-
tion during glucose deprivation. This technique more
closely approximates the important clinical setting in
which regulation of glucagon secretion is most critical
(i.e., hypoglycemia). Moreover, our results support the
hypothesis that the association of high basal glucagon in
type 1 diabetes could at least in part be attributed to lack
of insulin-bound zinc tonically suppressing -cell function.
In conclusion, our results strongly implicate the -cell
KATP channel and calcium channel as obligate parts of the
mechanism whereby zinc suppresses glucagon secretion
from the -cell and whereby a sudden absence of zinc
secretion from the -cell during glucose deprivation trig-
gers glucagon secretion.
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